Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evemie Schutyser

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cytokine & Growth Factor Reviews|September 2, 2003
The CC chemokine CCL20 and its receptor CCR6Evemie Schutyser, Sofie Struyf, Jo Van Damme
Journal of Leukocyte Biology|March 24, 2005
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processesEvemie Schutyser, Ann Richmond, Jo Van Damme
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Posttranslational processing of chemokinesPaul Proost, Frank Mahieu, Evemie Schutyser, et al.
Cancer Research|June 3, 2006
Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cellsYukiko Ueda, Nicole F Neel, Evemie Schutyser, et al.
Cytokine & Growth Factor Reviews|July 7, 2005
Chemokine receptor internalization and intracellular traffickingNicole F Neel, Evemie Schutyser, Jiqing Sai, et al.
European Cytokine Network|June 28, 2007
Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cellsEvemie Schutyser, Yingjun Su, Yingchun Yu, et al.
Molecular Pharmacology|May 13, 2008
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated eventsMieke Gouwy, Sofie Struyf, Samuel Noppen, et al.
The American Journal of Pathology|October 28, 2003
PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemiaSofie Struyf, Evemie Schutyser, Mieke Gouwy, et al.
Journal of Leukocyte Biology|March 5, 2004
Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluidsPaul Proost, Sara Verpoest, Kirsten Van de Borne, et al.
Blood|March 17, 2007
Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migrationPaul Proost, Anneleen Mortier, Tamara Loos, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cytokine & Growth Factor Reviews|September 2, 2003
The CC chemokine CCL20 and its receptor CCR6Evemie Schutyser, Sofie Struyf, Jo Van Damme
Journal of Leukocyte Biology|March 24, 2005
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processesEvemie Schutyser, Ann Richmond, Jo Van Damme
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Posttranslational processing of chemokinesPaul Proost, Frank Mahieu, Evemie Schutyser, et al.
Cancer Research|June 3, 2006
Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cellsYukiko Ueda, Nicole F Neel, Evemie Schutyser, et al.
Cytokine & Growth Factor Reviews|July 7, 2005
Chemokine receptor internalization and intracellular traffickingNicole F Neel, Evemie Schutyser, Jiqing Sai, et al.
European Cytokine Network|June 28, 2007
Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cellsEvemie Schutyser, Yingjun Su, Yingchun Yu, et al.
Molecular Pharmacology|May 13, 2008
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated eventsMieke Gouwy, Sofie Struyf, Samuel Noppen, et al.
The American Journal of Pathology|October 28, 2003
PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemiaSofie Struyf, Evemie Schutyser, Mieke Gouwy, et al.
Journal of Leukocyte Biology|March 5, 2004
Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluidsPaul Proost, Sara Verpoest, Kirsten Van de Borne, et al.
Blood|March 17, 2007
Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migrationPaul Proost, Anneleen Mortier, Tamara Loos, et al.
Pageof 2